Harikrishnan; Lalgudi S.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Harikrishnan; Lalgudi S..The latest application filed is for "agonists of ror gammat".
- Harikrishnan; Lalgudi S. - Skillman NJ
- Harikrishnan; Lalgudi S. - Princeton NJ
| Patent | Date |
|---|---|
| AGONISTS OF ROR GAMMAt App 20220306630 - Harikrishnan; Lalgudi S. ; et al. | 2022-09-29 |
| Cyclic dinucleotides as anticancer agents Grant 11,339,185 - Fink , et al. May 24, 2 | 2022-05-24 |
| Cyclic Dinucleotides As Anticancer Agents App 20220117995 - FINK; Brian E. ; et al. | 2022-04-21 |
| Cyclic Dinucleotides As Anticancer Agents App 20200270298 - HARIKRISHNAN; Lalgudi S. ; et al. | 2020-08-27 |
| Cyclic dinucleotides as anticancer agents Grant 10,744,150 - Fink , et al. A | 2020-08-18 |
| Tricyclic compounds as anticancer agents Grant 10,683,290 - Quesnelle , et al. | 2020-06-16 |
| Cyclic Dinucleotides As Anticancer Agents App 20200079815 - FINK; Brian E. ; et al. | 2020-03-12 |
| Cyclic dinucleotides as anticancer agents Grant 10,519,187 - Fink , et al. Dec | 2019-12-31 |
| TGF beta receptor antagonists Grant 10,399,987 - Harikrishnan , et al. Sep | 2019-09-03 |
| Cyclic Dinucleotides As Anticancer Agents App 20190248828 - Fink; Brian E. ; et al. | 2019-08-15 |
| TGF.beta. receptor antagonist Grant 10,336,761 - Harikrishnan , et al. | 2019-07-02 |
| TGF beta receptor antagonists Grant 10,292,985 - Borzilleri , et al. | 2019-05-21 |
| Carbazole compounds useful as bromodomain inhibitors Grant 10,196,387 - Poss , et al. Fe | 2019-02-05 |
| Cyclic Dinucleotides As Anticancer Agents App 20190030057 - FINK; Brian E. ; et al. | 2019-01-31 |
| Tgf Beta Receptor Antagonists App 20180250303 - Borzilleri; Robert M. ; et al. | 2018-09-06 |
| Tgf Beta Receptor Antagonists App 20180243312 - BORZILLERI; Robert M. ; et al. | 2018-08-30 |
| Carbazole compounds useful as bromodomain inhibitors Grant 10,053,454 - Poss , et al. August 21, 2 | 2018-08-21 |
| Tgf Beta Receptor Antagonists App 20180215762 - HARIKRISHNAN; Lalgudi S. ; et al. | 2018-08-02 |
| Tgf Beta Receptor Antagonists App 20180215761 - HARIKRISHNAN; Lalgudi S. ; et al. | 2018-08-02 |
| Tricyclic Compounds As Anticancer Agents App 20180127413 - QUESNELLE; Claude A. ; et al. | 2018-05-10 |
| Carbazole Compounds Useful As Bromodomain Inhibitors App 20170152248 - Poss; Michael A. ; et al. | 2017-06-01 |
| Carbazole Compounds Useful As Bromodomain Inhibitors App 20160009701 - Poss; Michael A. ; et al. | 2016-01-14 |
| Heterocyclic CETP inhibitors Grant 8,642,576 - Salvati , et al. February 4, 2 | 2014-02-04 |
| Pyrrolotriazine kinase inhibitors Grant 8,445,676 - Purandare , et al. May 21, 2 | 2013-05-21 |
| Heterocyclic Cetp Inhibitors App 20120322761 - Salvati; Mark E. ; et al. | 2012-12-20 |
| Heterocyclic CETP inhibitors Grant 8,304,403 - Salvati , et al. November 6, 2 | 2012-11-06 |
| Pyrrolotriazine Kinase Inhibitors App 20110294816 - Purandare; Ashok Vinayak ; et al. | 2011-12-01 |
| Heterocyclic CETP inhibitors Grant 7,888,376 - Salvati , et al. February 15, 2 | 2011-02-15 |
| Heterocyclic Cetp Inhibitors App 20100267669 - Salvati; Mark E. ; et al. | 2010-10-21 |
| Heterocyclic CETP inhibitors Grant 7,790,770 - Salvati , et al. September 7, 2 | 2010-09-07 |
| Fused cyclic modulators of nuclear hormone receptor function Grant 7,432,267 - Salvati , et al. October 7, 2 | 2008-10-07 |
| Heterocyclic Cetp Inhibitors App 20070161685 - Salvati; Mark E. ; et al. | 2007-07-12 |
| Heterocyclic Cetp Inhibitors App 20070135631 - Salvati; Mark E. ; et al. | 2007-06-14 |
| Fused cyclic modulators of nuclear hormone receptor function Grant 7,001,911 - Salvati , et al. February 21, 2 | 2006-02-21 |
| Fused cyclic modulators of nuclear hormone receptor function App 20050282813 - Salvati, Mark E. ; et al. | 2005-12-22 |
| Fused cyclic modulators of nuclear hormone receptor function App 20040077606 - Salvati, Mark E. ; et al. | 2004-04-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 